{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:53:23Z","timestamp":1792288403213,"version":"4.4.0"},"publisher-location":"Cham","reference-count":103,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030217365","type":"print"},{"value":"9783030217372","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-21737-2_8","type":"book-chapter","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T18:02:33Z","timestamp":1563818553000},"page":"151-165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":218,"title":["Pharmacology of Medical Cannabis"],"prefix":"10.1007","author":[{"given":"Md Ruhul","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan W.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,23]]},"reference":[{"issue":"Pt B","key":"8_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.yebeh.2016.11.033","volume":"70","author":"D Friedman","year":"2017","unstructured":"Friedman D, Sirven JI (2017) Historical perspective on the medical use of cannabis for epilepsy: ancient times to the 1980s. Epilepsy Behav 70(Pt B):298\u2013301","journal-title":"Epilepsy Behav"},{"issue":"Pt B","key":"8_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.yebeh.2016.09.040","volume":"70","author":"EB Russo","year":"2017","unstructured":"Russo EB (2017) Cannabis and epilepsy: an ancient treatment returns to the fore. Epilepsy Behav 70(Pt B):292\u2013297","journal-title":"Epilepsy Behav"},{"issue":"3","key":"8_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5055\/jom.2009.0016","volume":"5","author":"SK Aggarwal","year":"2009","unstructured":"Aggarwal SK, Carter GT, Sullivan MD, ZumBrunnen C, Morrill R, Mayer JD (2009) Medicinal use of cannabis in the United States: historical perspectives, current trends, and future directions. J Opioid Manag 5(3):153\u2013168","journal-title":"J Opioid Manag"},{"issue":"2","key":"8_CR4","first-page":"95","volume":"8","author":"HA Epstein","year":"2010","unstructured":"Epstein HA (2010) A natural approach to soothing atopic skin. Skinmed 8(2):95\u201397","journal-title":"Skinmed"},{"issue":"10","key":"8_CR5","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1177\/0959683616650268","volume":"26","author":"CJ Stevens","year":"2016","unstructured":"Stevens CJ, Murphy C, Roberts R, Lucas L, Silva F, Fuller DQ (2016) Between China and South Asia: a middle Asian corridor of crop dispersal and agricultural innovation in the Bronze Age. The Holocene 26(10):1541\u20131555","journal-title":"The Holocene"},{"issue":"3","key":"8_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jep.2006.05.034","volume":"108","author":"HE Jiang","year":"2006","unstructured":"Jiang HE, Li X, Zhao YX, Ferguson DK, Hueber F, Bera S et al (2006) A new insight into Cannabis sativa (Cannabaceae) utilization from 2500-year-old Yanghai Tombs, Xinjiang, China. J Ethnopharmacol 108(3):414\u2013422","journal-title":"J Ethnopharmacol"},{"key":"8_CR7","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jep.2018.09.004","volume":"227","author":"SA Bonini","year":"2018","unstructured":"Bonini SA, Premoli M, Tambaro S, Kumar A, Maccarinelli G, Memo M et al (2018) Cannabis sativa: a comprehensive ethnopharmacological review of a medicinal plant with a long history. J Ethnopharmacol 227:300\u2013315","journal-title":"J Ethnopharmacol"},{"issue":"12","key":"8_CR8","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1039\/C6NP00074F","volume":"33","author":"LO Hanus","year":"2016","unstructured":"Hanus LO, Meyer SM, Munoz E, Taglialatela-Scafati O, Appendino G (2016) Phytocannabinoids: a unified critical inventory. Nat Prod Rep 33(12):1357\u20131392","journal-title":"Nat Prod Rep"},{"issue":"1","key":"8_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pharmthera.2011.09.002","volume":"133","author":"AJ Hill","year":"2012","unstructured":"Hill AJ, Williams CM, Whalley BJ, Stephens GJ (2012) Phytocannabinoids as novel therapeutic agents in CNS disorders. Pharmacol Ther 133(1):79\u201397","journal-title":"Pharmacol Ther"},{"issue":"6284","key":"8_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346(6284):561\u2013564","journal-title":"Nature"},{"issue":"23","key":"8_CR11","doi-asserted-by":"publisher","first-page":"7142","DOI":"10.1093\/nar\/18.23.7142","volume":"18","author":"C Gerard","year":"1990","unstructured":"Gerard C, Mollereau C, Vassart G, Parmentier M (1990) Nucleotide sequence of a human cannabinoid receptor cDNA. Nucleic Acids Res 18(23):7142","journal-title":"Nucleic Acids Res"},{"issue":"6441","key":"8_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365(6441):61\u201365","journal-title":"Nature"},{"key":"8_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1042\/bj2790129","volume":"279","author":"CM Gerard","year":"1991","unstructured":"Gerard CM, Mollereau C, Vassart G, Parmentier M (1991) Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J 279. (Pt 1:129\u2013134","journal-title":"Biochem J"},{"issue":"2","key":"8_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"AC Howlett","year":"2002","unstructured":"Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA et al (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54(2):161\u2013202","journal-title":"Pharmacol Rev"},{"key":"8_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neubiorev.2018.12.026","volume":"98","author":"CJ Jordan","year":"2019","unstructured":"Jordan CJ, Xi ZX (2019) Progress in brain cannabinoid CB2 receptor research: from genes to behavior. Neurosci Biobehav Rev 98:208\u2013220","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"8_CR16","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","volume":"87","author":"M Herkenham","year":"1990","unstructured":"Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR et al (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 87(5):1932\u20131936","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"8_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG (2008) The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol 153(2):199\u2013215","journal-title":"Br J Pharmacol"},{"issue":"1\u20132","key":"8_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0009-3084(00)00187-0","volume":"108","author":"AC Howlett","year":"2000","unstructured":"Howlett AC, Mukhopadhyay S (2000) Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem Phys Lipids 108(1\u20132):53\u201370","journal-title":"Chem Phys Lipids"},{"issue":"4","key":"8_CR19","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/0006-2952(94)90134-1","volume":"47","author":"SR Childers","year":"1994","unstructured":"Childers SR, Sexton T, Roy MB (1994) Effects of anandamide on cannabinoid receptors in rat brain membranes. Biochem Pharmacol 47(4):711\u2013715","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"8_CR20","first-page":"1045","volume":"57","author":"W Gonsiorek","year":"2000","unstructured":"Gonsiorek W, Lunn C, Fan X, Narula S, Lundell D, Hipkin RW (2000) Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol Pharmacol 57(5):1045\u20131050","journal-title":"Mol Pharmacol"},{"issue":"20","key":"8_CR21","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1021\/jm970126f","volume":"40","author":"MH Rhee","year":"1997","unstructured":"Rhee MH, Vogel Z, Barg J, Bayewitch M, Levy R, Hanus L et al (1997) Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase. J Med Chem 40(20):3228\u20133233","journal-title":"J Med Chem"},{"issue":"4","key":"8_CR22","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1046\/j.1471-4159.1998.71041525.x","volume":"71","author":"MH Rhee","year":"1998","unstructured":"Rhee MH, Bayewitch M, Avidor-Reiss T, Levy R, Vogel Z (1998) Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes. J Neurochem 71(4):1525\u20131534","journal-title":"J Neurochem"},{"issue":"3","key":"8_CR23","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2016.10.004","volume":"167","author":"T Hua","year":"2016","unstructured":"Hua T, Vemuri K, Pu M, Qu L, Han GW, Wu Y et al (2016) Crystal structure of the human cannabinoid receptor CB1. Cell 167(3):750\u201362 e14","journal-title":"Cell"},{"issue":"7","key":"8_CR24","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","volume":"152","author":"E Ryberg","year":"2007","unstructured":"Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J et\u00a0al (2007) The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152(7):1092\u20131101","journal-title":"Br J Pharmacol"},{"issue":"7","key":"8_CR25","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1073\/pnas.0711278105","volume":"105","author":"JE Lauckner","year":"2008","unstructured":"Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K (2008) GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci U S A 105(7):2699\u20132704","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"8_CR26","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.1073\/pnas.1211204110","volume":"110","author":"S Sylantyev","year":"2013","unstructured":"Sylantyev S, Jensen TP, Ross RA, Rusakov DA (2013) Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses. Proc Natl Acad Sci U S A 110(13):5193\u20135198","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6743","key":"8_CR27","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/22761","volume":"400","author":"PM Zygmunt","year":"1999","unstructured":"Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V et al (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400(6743):452\u2013457","journal-title":"Nature"},{"issue":"1","key":"8_CR28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/cphy.c120001","volume":"3","author":"J Zheng","year":"2013","unstructured":"Zheng J (2013) Molecular mechanism of TRP channels. Compr Physiol 3(1):221\u2013242","journal-title":"Compr Physiol"},{"issue":"5","key":"8_CR29","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1523\/JNEUROSCI.1565-06.2008","volume":"28","author":"AN Akopian","year":"2008","unstructured":"Akopian AN, Ruparel NB, Patwardhan A, Hargreaves KM (2008) Cannabinoids desensitize capsaicin and mustard oil responses in sensory neurons via TRPA1 activation. J Neurosci 28(5):1064\u20131075","journal-title":"J Neurosci"},{"issue":"1","key":"8_CR30","doi-asserted-by":"publisher","first-page":"C92","DOI":"10.1152\/ajpcell.00023.2008","volume":"295","author":"D Kim","year":"2008","unstructured":"Kim D, Cavanaugh EJ, Simkin D (2008) Inhibition of transient receptor potential A1 channel by phosphatidylinositol-4,5-bisphosphate. Am J Physiol Cell Physiol 295(1):C92\u2013C99","journal-title":"Am J Physiol Cell Physiol"},{"issue":"24","key":"8_CR31","doi-asserted-by":"publisher","first-page":"6231","DOI":"10.1523\/JNEUROSCI.0504-08.2008","volume":"28","author":"N Qin","year":"2008","unstructured":"Qin N, Neeper MP, Liu Y, Hutchinson TL, Lubin ML, Flores CM (2008) TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. J Neurosci 28(24):6231\u20136238","journal-title":"J Neurosci"},{"issue":"4","key":"8_CR32","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.neuroscience.2006.02.074","volume":"139","author":"L Cristino","year":"2006","unstructured":"Cristino L, de Petrocellis L, Pryce G, Baker D, Guglielmotti V, Di Marzo V (2006) Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 139(4):1405\u20131415","journal-title":"Neuroscience"},{"issue":"4","key":"8_CR33","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0306-4522(00)00389-4","volume":"100","author":"J Ahluwalia","year":"2000","unstructured":"Ahluwalia J, Urban L, Capogna M, Bevan S, Nagy I (2000) Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience 100(4):685\u2013688","journal-title":"Neuroscience"},{"issue":"5","key":"8_CR34","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0959-4388(99)00009-4","volume":"9","author":"MJ Caterina","year":"1999","unstructured":"Caterina MJ, Julius D (1999) Sense and specificity: a molecular identity for nociceptors. Curr Opin Neurobiol 9(5):525\u2013530","journal-title":"Curr Opin Neurobiol"},{"issue":"3","key":"8_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1507\/endocrj.49.349","volume":"49","author":"T Kowase","year":"2002","unstructured":"Kowase T, Nakazato Y, Yoko OH, Morikawa A, Kojima I (2002) Immunohistochemical localization of growth factor-regulated channel (GRC) in human tissues. Endocr J 49(3):349\u2013355","journal-title":"Endocr J"},{"issue":"6","key":"8_CR36","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0092-8674(03)00158-2","volume":"112","author":"GM Story","year":"2003","unstructured":"Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR et al (2003) ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112(6):819\u2013829","journal-title":"Cell"},{"issue":"6","key":"8_CR37","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1177\/154405910708600612","volume":"86","author":"A Diogenes","year":"2007","unstructured":"Diogenes A, Akopian AN, Hargreaves KM (2007) NGF up-regulates TRPA1: implications for orofacial pain. J Dent Res 86(6):550\u2013555","journal-title":"J Dent Res"},{"issue":"7","key":"8_CR38","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/hipo.20294","volume":"17","author":"MJ Diogenes","year":"2007","unstructured":"Diogenes MJ, Assaife-Lopes N, Pinto-Duarte A, Ribeiro JA, Sebastiao AM (2007) Influence of age on BDNF modulation of hippocampal synaptic transmission: interplay with adenosine A2A receptors. Hippocampus 17(7):577\u2013585","journal-title":"Hippocampus"},{"issue":"2","key":"8_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/hup.369","volume":"17","author":"GG Nahas","year":"2002","unstructured":"Nahas GG, Frick HC, Lattimer JK, Latour C, Harvey D (2002) Pharmacokinetics of THC in brain and testis, male gametotoxicity and premature apoptosis of spermatozoa. Hum Psychopharmacol 17(2):103\u2013113","journal-title":"Hum Psychopharmacol"},{"key":"8_CR40","first-page":"42","volume":"99","author":"M Perez-Reyes","year":"1990","unstructured":"Perez-Reyes M (1990) Marijuana smoking: factors that influence the bioavailability of tetrahydrocannabinol. NIDA Res Monogr 99:42\u201362","journal-title":"NIDA Res Monogr"},{"issue":"8","key":"8_CR41","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/cbdv.200790152","volume":"4","author":"MA Huestis","year":"2007","unstructured":"Huestis MA (2007) Human cannabinoid pharmacokinetics. Chem Biodivers 4(8):1770\u20131804","journal-title":"Chem Biodivers"},{"issue":"Suppl A","key":"8_CR42","doi-asserted-by":"publisher","first-page":"15A","DOI":"10.1155\/2005\/242516","volume":"10","author":"IJ McGilveray","year":"2005","unstructured":"McGilveray IJ (2005) Pharmacokinetics of cannabinoids. Pain Res Manag 10(Suppl A):15A\u201322A","journal-title":"Pain Res Manag"},{"issue":"6","key":"8_CR43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/jat\/20.6.441","volume":"20","author":"MA Huestis","year":"1996","unstructured":"Huestis MA, Mitchell JM, Cone EJ (1996) Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana. J Anal Toxicol 20(6):441\u2013452","journal-title":"J Anal Toxicol"},{"issue":"5","key":"8_CR44","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/jat\/16.5.276","volume":"16","author":"MA Huestis","year":"1992","unstructured":"Huestis MA, Henningfield JE, Cone EJ (1992) Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol 16(5):276\u2013282","journal-title":"J Anal Toxicol"},{"issue":"1","key":"8_CR45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/clpt.1992.100","volume":"52","author":"MA Huestis","year":"1992","unstructured":"Huestis MA, Sampson AH, Holicky BJ, Henningfield JE, Cone EJ (1992) Characterization of the absorption phase of marijuana smoking. Clin Pharmacol Ther 52(1):31\u201341","journal-title":"Clin Pharmacol Ther"},{"issue":"4049","key":"8_CR46","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1126\/science.177.4049.633","volume":"177","author":"M Perez-Reyes","year":"1972","unstructured":"Perez-Reyes M, Timmons MC, Lipton MA, Davis KH, Wall ME (1972) Intravenous injection in man of 9 -tetrahydrocannabinol and 11-OH- 9 -tetrahydrocannabinol. Science 177(4049):633\u2013635","journal-title":"Science"},{"issue":"2","key":"8_CR47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1124\/pr.117.014399","volume":"70","author":"SRA Alles","year":"2018","unstructured":"Alles SRA, Smith PA (2018) Etiology and pharmacology of neuropathic pain. Pharmacol Rev 70(2):315\u2013347","journal-title":"Pharmacol Rev"},{"issue":"7","key":"8_CR48","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1212\/01.wnl.0000253187.66183.9c","volume":"68","author":"DI Abrams","year":"2007","unstructured":"Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S et al (2007) Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology 68(7):515\u2013521","journal-title":"Neurology"},{"issue":"3","key":"8_CR49","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/npp.2008.120","volume":"34","author":"RJ Ellis","year":"2009","unstructured":"Ellis RJ, Toperoff W, Vaida F, van den Brande G, Gonzales J, Gouaux B et al (2009) Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology 34(3):672\u2013680","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"8_CR50","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jpain.2007.12.010","volume":"9","author":"B Wilsey","year":"2008","unstructured":"Wilsey B, Marcotte T, Tsodikov A, Millman J, Bentley H, Gouaux B et al (2008) A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. J Pain 9(6):506\u2013521","journal-title":"J Pain"},{"issue":"2","key":"8_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/phar.1187","volume":"33","author":"LM Borgelt","year":"2013","unstructured":"Borgelt LM, Franson KL, Nussbaum AM, Wang GS (2013) The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy 33(2):195\u2013209","journal-title":"Pharmacotherapy"},{"issue":"9","key":"8_CR52","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.clinthera.2007.09.013","volume":"29","author":"DJ Rog","year":"2007","unstructured":"Rog DJ, Nurmikko TJ, Young CA (2007) Oromucosal delta9-tetrahydrocannabinol\/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial. Clin Ther 29(9):2068\u20132079","journal-title":"Clin Ther"},{"issue":"1\u20133","key":"8_CR53","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.pain.2007.08.028","volume":"133","author":"TJ Nurmikko","year":"2007","unstructured":"Nurmikko TJ, Serpell MG, Hoggart B, Toomey PJ, Morlion BJ, Haines D (2007) Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial. Pain 133(1\u20133):210\u2013220","journal-title":"Pain"},{"issue":"38","key":"8_CR54","first-page":"627","volume":"114","author":"W Hauser","year":"2017","unstructured":"Hauser W, Fitzcharles MA, Radbruch L, Petzke F (2017) Cannabinoids in pain management and palliative medicine. Deutsches Arzteblatt Int 114(38):627\u2013634","journal-title":"Deutsches Arzteblatt Int"},{"issue":"1","key":"8_CR55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00482-015-0084-3","volume":"30","author":"MA Fitzcharles","year":"2016","unstructured":"Fitzcharles MA, Baerwald C, Ablin J, Hauser W (2016) Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): a systematic review of randomized controlled trials. Schmerz 30(1):47\u201361","journal-title":"Schmerz"},{"issue":"5","key":"8_CR56","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/acr.22727","volume":"68","author":"MA Fitzcharles","year":"2016","unstructured":"Fitzcharles MA, Ste-Marie PA, Hauser W, Clauw DJ, Jamal S, Karsh J et\u00a0al (2016) Efficacy, tolerability, and safety of cannabinoid treatments in the rheumatic diseases: a systematic review of randomized controlled trials. Arthritis Care Res (Hoboken) 68(5):681\u2013688","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"8_CR57","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00482-015-0087-0","volume":"30","author":"MS Volz","year":"2016","unstructured":"Volz MS, Siegmund B, Hauser W (2016) Efficacy, tolerability, and safety of cannabinoids in gastroenterology: a systematic review. Schmerz 30(1):37\u201346","journal-title":"Schmerz"},{"issue":"7","key":"8_CR58","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cgh.2016.09.147","volume":"15","author":"M Vries de","year":"2017","unstructured":"de Vries M, van Rijckevorsel DCM, Vissers KCP, Wilder-Smith OHG, van Goor H (2017) Tetrahydrocannabinol does not reduce pain in patients with chronic abdominal pain in a phase 2 placebo-controlled study. Clin Gastroenterol Hepatol 15(7):1079\u20131086. e4","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"8_CR59","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1124\/jpet.113.206003","volume":"346","author":"LK Brents","year":"2013","unstructured":"Brents LK, Zimmerman SM, Saffell AR, Prather PL, Fantegrossi WE (2013) Differential drug-drug interactions of the synthetic cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy. J Pharmacol Exp Ther 346(3):350\u2013361","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"8_CR60","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","volume":"30","author":"AA Izzo","year":"2009","unstructured":"Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R (2009) Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 30(10):515\u2013527","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"8_CR61","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nn1916","volume":"10","author":"N Agarwal","year":"2007","unstructured":"Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin CE, Brenner GJ et al (2007) Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci 10(7):870\u2013879","journal-title":"Nat Neurosci"},{"issue":"30","key":"8_CR62","doi-asserted-by":"publisher","first-page":"11393","DOI":"10.1073\/pnas.0603861103","volume":"103","author":"AM Patwardhan","year":"2006","unstructured":"Patwardhan AM, Jeske NA, Price TJ, Gamper N, Akopian AN, Hargreaves KM (2006) The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin. Proc Natl Acad Sci U S A 103(30):11393\u201311398","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"8_CR63","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1097\/j.pain.0000000000001052","volume":"158","author":"HT Philpott","year":"2017","unstructured":"Philpott HT, O\u2019Brien M, McDougall JJ (2017) Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. Pain 158(12):2442\u20132451","journal-title":"Pain"},{"key":"8_CR64","first-page":"225","volume":"2","author":"V Barrese","year":"2010","unstructured":"Barrese V, Miceli F, Soldovieri MV, Ambrosino P, Iannotti FA, Cilio MR et al (2010) Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine. Clin Pharmacol 2:225\u2013236","journal-title":"Clin Pharmacol"},{"key":"8_CR65","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.yebeh.2015.06.044","volume":"50","author":"AD Korczyn","year":"2015","unstructured":"Korczyn AD, Schachter SC, Amlerova J, Bialer M, van Emde Boas W, Brazdil M et al (2015) Third international congress on epilepsy, brain and mind: Part 1. Epilepsy Behav 50:116\u2013137","journal-title":"Epilepsy Behav"},{"key":"8_CR66","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.yebeh.2015.07.014","volume":"50","author":"I Rektor","year":"2015","unstructured":"Rektor I, Schachter SC, Arya R, Arzy S, Braakman H, Brodie MJ et al (2015) Third international congress on epilepsy, brain, and mind: part 2. Epilepsy Behav 50:138\u2013159","journal-title":"Epilepsy Behav"},{"issue":"2","key":"8_CR67","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/epi.12056","volume":"54","author":"DC Hesdorffer","year":"2013","unstructured":"Hesdorffer DC, Beck V, Begley CE, Bishop ML, Cushner-Weinstein S, Holmes GL et al (2013) Research implications of the institute of medicine report, epilepsy across the Spectrum: promoting health and understanding. Epilepsia 54(2):207\u2013216","journal-title":"Epilepsia"},{"key":"8_CR68","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fneur.2017.00301","volume":"8","author":"F Tang","year":"2017","unstructured":"Tang F, Hartz AMS, Bauer B (2017) Drug-resistant epilepsy: multiple hypotheses, few answers. Front Neurol 8:301","journal-title":"Front Neurol"},{"issue":"8","key":"8_CR69","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1111\/j.1476-5381.2012.02207.x","volume":"167","author":"AJ Hill","year":"2012","unstructured":"Hill AJ, Mercier MS, Hill TD, Glyn SE, Jones NA, Yamasaki Y et al (2012) Cannabidivarin is anticonvulsant in mouse and rat. Br J Pharmacol 167(8):1629\u20131642","journal-title":"Br J Pharmacol"},{"issue":"3","key":"8_CR70","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/bph.12321","volume":"170","author":"TD Hill","year":"2013","unstructured":"Hill TD, Cascio MG, Romano B, Duncan M, Pertwee RG, Williams CM et al (2013) Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism. Br J Pharmacol 170(3):679\u2013692","journal-title":"Br J Pharmacol"},{"issue":"5","key":"8_CR71","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.seizure.2012.03.001","volume":"21","author":"NA Jones","year":"2012","unstructured":"Jones NA, Glyn SE, Akiyama S, Hill TD, Hill AJ, Weston SE et al (2012) Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures. Seizure 21(5):344\u2013352","journal-title":"Seizure"},{"issue":"1","key":"8_CR72","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0014-2999(01)01243-2","volume":"428","author":"MJ Wallace","year":"2001","unstructured":"Wallace MJ, Wiley JL, Martin BR, DeLorenzo RJ (2001) Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. Eur J Pharmacol 428(1):51\u201357","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"8_CR73","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0014-2999(02)02331-2","volume":"452","author":"MJ Wallace","year":"2002","unstructured":"Wallace MJ, Martin BR, DeLorenzo RJ (2002) Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol 452(3):295\u2013301","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"8_CR74","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1016\/j.pnpbp.2011.07.001","volume":"35","author":"JJ Luszczki","year":"2011","unstructured":"Luszczki JJ, Andres-Mach M, Barcicka-Klosowska B, Florek-Luszczki M, Haratym-Maj A, Czuczwar SJ (2011) Effects of WIN 55,212-2 mesylate (a synthetic cannabinoid) on the protective action of clonazepam, ethosuximide, phenobarbital and valproate against pentylenetetrazole-induced clonic seizures in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 35(8):1870\u20131876","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"2","key":"8_CR75","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.pbb.2011.01.002","volume":"98","author":"JJ Luszczki","year":"2011","unstructured":"Luszczki JJ, Misiuta-Krzesinska M, Florek M, Tutka P, Czuczwar SJ (2011) Synthetic cannabinoid WIN 55,212-2 mesylate enhances the protective action of four classical antiepileptic drugs against maximal electroshock-induced seizures in mice. Pharmacol Biochem Behav 98(2):261\u2013267","journal-title":"Pharmacol Biochem Behav"},{"issue":"3936","key":"8_CR76","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1126\/science.168.3936.1159","volume":"168","author":"R Mechoulam","year":"1970","unstructured":"Mechoulam R (1970) Marihuana chemistry. Science 168(3936):1159\u20131166","journal-title":"Science"},{"issue":"3","key":"8_CR77","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000137430","volume":"21","author":"JM Cunha","year":"1980","unstructured":"Cunha JM, Carlini EA, Pereira AE, Ramos OL, Pimentel C, Gagliardi R et al (1980) Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology 21(3):175\u2013185","journal-title":"Pharmacology"},{"issue":"7","key":"8_CR78","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.braindev.2018.03.013","volume":"40","author":"M Hausman-Kedem","year":"2018","unstructured":"Hausman-Kedem M, Menascu S, Kramer U (2018) Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents\u00a0\u2013 an observational, longitudinal study. Brain Dev 40(7):544\u2013551","journal-title":"Brain Dev"},{"issue":"4","key":"8_CR79","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0301-0082(02)00080-1","volume":"68","author":"BE Alger","year":"2002","unstructured":"Alger BE (2002) Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 68(4):247\u2013286","journal-title":"Prog Neurobiol"},{"key":"8_CR80","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev.neuro.29.051605.112834","volume":"29","author":"V Chevaleyre","year":"2006","unstructured":"Chevaleyre V, Takahashi KA, Castillo PE (2006) Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29:37\u201376","journal-title":"Annu Rev Neurosci"},{"issue":"3 Suppl","key":"8_CR81","first-page":"27","volume":"29","author":"G Marsicano","year":"2006","unstructured":"Marsicano G, Lutz B (2006) Neuromodulatory functions of the endocannabinoid system. J Endocrinol Investig 29(3 Suppl):27\u201346","journal-title":"J Endocrinol Investig"},{"issue":"5642","key":"8_CR82","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1088208","volume":"302","author":"G Marsicano","year":"2003","unstructured":"Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A et al (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302(5642):84\u201388","journal-title":"Science"},{"issue":"5","key":"8_CR83","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/sj.bjp.0705466","volume":"140","author":"GL Gerdeman","year":"2003","unstructured":"Gerdeman GL, Lovinger DM (2003) Emerging roles for endocannabinoids in long-term synaptic plasticity. Br J Pharmacol 140(5):781\u2013789","journal-title":"Br J Pharmacol"},{"issue":"1","key":"8_CR84","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1124\/jpet.103.051920","volume":"307","author":"MJ Wallace","year":"2003","unstructured":"Wallace MJ, Blair RE, Falenski KW, Martin BR, DeLorenzo RJ (2003) The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J Pharmacol Exp Ther 307(1):129\u2013137","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"8_CR85","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","volume":"51","author":"K Monory","year":"2006","unstructured":"Monory K, Massa F, Egertova M, Eder M, Blaudzun H, Westenbroek R et al (2006) The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51(4):455\u2013466","journal-title":"Neuron"},{"issue":"12","key":"8_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015707","volume":"5","author":"S Guggenhuber","year":"2010","unstructured":"Guggenhuber S, Monory K, Lutz B, Klugmann M (2010) AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity. PLoS One 5(12):e15707","journal-title":"PLoS One"},{"issue":"9","key":"8_CR87","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1073\/pnas.89.9.3825","volume":"89","author":"K Mackie","year":"1992","unstructured":"Mackie K, Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci U S A 89(9):3825\u20133829","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23\u201324","key":"8_CR88","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/0024-3205(95)00192-9","volume":"56","author":"RE Hampson","year":"1995","unstructured":"Hampson RE, Evans GJ, Mu J, Zhuang SY, King VC, Childers SR et al (1995) Role of cyclic AMP dependent protein kinase in cannabinoid receptor modulation of potassium \u201cA-current\u201d in cultured rat hippocampal neurons. Life Sci 56(23\u201324):2081\u20132088","journal-title":"Life Sci"},{"issue":"10","key":"8_CR89","doi-asserted-by":"publisher","first-page":"6552","DOI":"10.1523\/JNEUROSCI.15-10-06552.1995","volume":"15","author":"K Mackie","year":"1995","unstructured":"Mackie K, Lai Y, Westenbroek R, Mitchell R (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15(10):6552\u20136561","journal-title":"J Neurosci"},{"key":"8_CR90","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2377-9-59","volume":"9","author":"SE Lakhan","year":"2009","unstructured":"Lakhan SE, Rowland M (2009) Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review. BMC Neurol 9:59","journal-title":"BMC Neurol"},{"issue":"1","key":"8_CR91","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1185\/030079906X158066","volume":"23","author":"M Iskedjian","year":"2007","unstructured":"Iskedjian M, Bereza B, Gordon A, Piwko C, Einarson TR (2007) Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain. Curr Med Res Opin 23(1):17\u201324","journal-title":"Curr Med Res Opin"},{"issue":"Pt 10","key":"8_CR92","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1093\/brain\/awm160","volume":"130","author":"D Centonze","year":"2007","unstructured":"Centonze D, Bari M, Rossi S, Prosperetti C, Furlan R, Fezza F et al (2007) The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. Brain 130(Pt 10):2543\u20132553","journal-title":"Brain"},{"key":"8_CR93","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0074-7742(07)82009-5","volume":"82","author":"D Centonze","year":"2007","unstructured":"Centonze D, Rossi S, Finazzi-Agro A, Bernardi G, Maccarrone M (2007) The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis. Int Rev Neurobiol 82:171\u2013186","journal-title":"Int Rev Neurobiol"},{"issue":"1\u20132","key":"8_CR94","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jns.2009.07.021","volume":"287","author":"L Jean-Gilles","year":"2009","unstructured":"Jean-Gilles L, Feng S, Tench CR, Chapman V, Kendall DA, Barrett DA et al (2009) Plasma endocannabinoid levels in multiple sclerosis. J Neurol Sci 287(1\u20132):212\u2013215","journal-title":"J Neurol Sci"},{"issue":"Pt 10","key":"8_CR95","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1093\/brain\/awg224","volume":"126","author":"G Pryce","year":"2003","unstructured":"Pryce G, Ahmed Z, Hankey DJ, Jackson SJ, Croxford JL, Pocock JM et al (2003) Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain 126(Pt 10):2191\u20132202","journal-title":"Brain"},{"issue":"4","key":"8_CR96","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","volume":"10","author":"DT Wade","year":"2004","unstructured":"Wade DT, Makela P, Robson P, House H, Bateman C (2004) Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult Scler 10(4):434\u2013441","journal-title":"Mult Scler"},{"issue":"6","key":"8_CR97","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1177\/1352458510367462","volume":"16","author":"DT Wade","year":"2010","unstructured":"Wade DT, Collin C, Stott C, Duncombe P (2010) Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis. Mult Scler 16(6):707\u2013714","journal-title":"Mult Scler"},{"issue":"3","key":"8_CR98","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0306-4522(94)90511-8","volume":"63","author":"TM Westlake","year":"1994","unstructured":"Westlake TM, Howlett AC, Bonner TI, Matsuda LA, Herkenham M (1994) Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer\u2019s brains. Neuroscience 63(3):637\u2013652","journal-title":"Neuroscience"},{"issue":"8","key":"8_CR99","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","volume":"25","author":"BG Ramirez","year":"2005","unstructured":"Ramirez BG, Blazquez C, Gomez del Pulgar T, Guzman M, de Ceballos ML (2005) Prevention of Alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 25(8):1904\u20131913","journal-title":"J Neurosci"},{"issue":"35","key":"8_CR100","doi-asserted-by":"publisher","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","volume":"23","author":"C Benito","year":"2003","unstructured":"Benito C, Nunez E, Tolon RM, Carrier EJ, Rabano A, Hillard CJ et al (2003) Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer\u2019s disease brains. J Neurosci 23(35):11136\u201311141","journal-title":"J Neurosci"},{"issue":"16","key":"8_CR101","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.lfs.2004.03.026","volume":"75","author":"MR Pazos","year":"2004","unstructured":"Pazos MR, Nunez E, Benito C, Tolon RM, Romero J (2004) Role of the endocannabinoid system in Alzheimer\u2019s disease: new perspectives. Life Sci 75(16):1907\u20131915","journal-title":"Life Sci"},{"issue":"6","key":"8_CR102","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1021\/mp060066m","volume":"3","author":"LM Eubanks","year":"2006","unstructured":"Eubanks LM, Rogers CJ, AEt B, Koob GF, Olson AJ, Dickerson TJ et al (2006) A molecular link between the active component of marijuana and Alzheimer\u2019s disease pathology. Mol Pharm 3(6):773\u2013777","journal-title":"Mol Pharm"},{"issue":"2","key":"8_CR103","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0304-3940(02)00936-9","volume":"332","author":"NG Milton","year":"2002","unstructured":"Milton NG (2002) Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. Neurosci Lett 332(2):127\u2013130","journal-title":"Neurosci Lett"}],"container-title":["Advances in Experimental Medicine and Biology","Recent Advances in Cannabinoid Physiology and Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-21737-2_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T10:30:39Z","timestamp":1664015439000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-21737-2_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030217365","9783030217372"],"references-count":103,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-21737-2_8","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"23 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}